Enterprise Value
$12.47 B
-$1.05 B-7.75%
1 min ago
Summary
- As of February 7, 2025, NBIX enterprise value is $12.47 billion, with a fall of -$1.05 billion (-7.75%) during the most recent trading day.
- Over the past year, NBIX enterprise value has dropped by -$1.19 billion (-8.71%).
- NBIX enterprise value is now -20.91% below its all-time high of $15.77 billion.
Performance
NBIX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
NBIX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -7.8% | -7.7% | -7.7% |
| 1 m1 month | -9.8% | -9.8% | -9.8% |
| 3 m3 months | -4.6% | -4.6% | -4.6% |
| 6 m6 months | -15.0% | -13.6% | -13.9% |
| ytdytd | -8.1% | -8.1% | -8.1% |
| 1 y1 year | -8.7% | -6.8% | -8.4% |
| 5 y5 years | +25.0% | +31.0% | +19.4% |
NBIX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -19.8% | $12 B | at low | |
| 3 m | 3-month | $16 B | -19.8% | $12 B | +6.1% |
| 6 m | 6-month | $16 B | -20.9% | $11 B | +12.3% |
| 1 y | 1-year | $16 B | -20.9% | $11 B | +12.3% |
| 3 y | 3-year | $16 B | -20.9% | $7.45 B | +67.3% |
| 5 y | 5-year | $16 B | -20.9% | $6.98 B | +78.8% |
| alltime | all time | $16 B | -20.9% | $5.84 M | >+9999.0% |
Neurocrine Biosciences Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $12.47 B(-8.1%) |
| 2024 | $13.57 B(+2.3%) |
| 2023 | $13.27 B(+15.2%) |
| 2022 | $11.53 B(+40.9%) |
| 2021 | $8.18 B(-10.9%) |
| 2020 | $9.19 B(-10.8%) |
| 2019 | $10.30 B(+53.1%) |
| 2018 | $6.73 B(-3.9%) |
| 2017 | $7.00 B(+113.6%) |
| 2016 | $3.28 B(-31.8%) |
| 2015 | $4.81 B(+186.5%) |
| 2014 | $1.68 B(+187.1%) |
| 2013 | $584.27 M(+34.9%) |
| 2012 | $433.27 M(+3.3%) |
| 2011 | $419.63 M(+14.9%) |
| Date | Value |
|---|---|
| 2010 | $365.25 M(+343.6%) |
| 2009 | $82.33 M(+16.9%) |
| 2008 | $70.44 M(-6.8%) |
| 2007 | $75.59 M(-79.4%) |
| 2006 | $367.64 M(-84.3%) |
| 2005 | $2.34 B(+29.5%) |
| 2004 | $1.81 B(-2.7%) |
| 2003 | $1.86 B(+36.1%) |
| 2002 | $1.36 B(-2.5%) |
| 2001 | $1.40 B(+70.3%) |
| 2000 | $821.33 M(+59.0%) |
| 1999 | $516.60 M(+325.4%) |
| 1998 | $121.45 M(-2.9%) |
| 1997 | $125.09 M(-28.1%) |
| 1996 | $174.00 M |
FAQ
- What is Neurocrine Biosciences enterprise value?
- What is the all time high enterprise value for Neurocrine Biosciences?
- What is NBIX enterprise value year-to-date change?
- What is Neurocrine Biosciences enterprise value year-on-year change?
What is Neurocrine Biosciences enterprise value?
The current enterprise value of NBIX is $12.47 B
What is the all time high enterprise value for Neurocrine Biosciences?
Neurocrine Biosciences all-time high enterprise value is $15.77 B
What is NBIX enterprise value year-to-date change?
Neurocrine Biosciences enterprise value has changed by -$1.10 B (-8.13%) since the beginning of the year
What is Neurocrine Biosciences enterprise value year-on-year change?
Over the past year, NBIX enterprise value has changed by -$1.19 B (-8.71%)